On Monday, October 5, 2026, Mississippi Attorney General Lynn Fitch announced a major $384 million settlement with Abbott Laboratories, resolving allegations that the company defrauded government health programs by selling infant formula and nutritional therapy products manufactured in facilities that failed to meet state and federal safety standards for preventing contamination. The settlement was reached jointly by Fitch, 39 other states, and the federal government. Under the terms, Abbott will pay approximately $348.7 million to the United States to resolve False Claims Act allegations and an additional $35.5 million to the states for claims related to Medicaid programs. Mississippi’s share of the recovery is $771,432.52 in restitution and other recoveries. In announcing the settlement, Fitch made clear that the case was about more than money. “Parents should be able to trust that the infant formula they feed their babies is safe, but Abbott betrayed that trust,” she said. “My office is dedicated to protecting the integrity of the Medicaid program and ensuring that Mississippians receive the necessities that their families rely on. This settlement holds Abbott accountable for knowingly manufacturing formula in substandard conditions and defrauding taxpayers.” The announcement represents a significant moment in the ongoing effort to hold large corporations accountable when taxpayer-funded programs are harmed by unsafe or noncompliant products.
At the center of the allegations are claims that Abbott knowingly manufactured infant formula purchased with taxpayer dollars in an environment that put products at an unacceptable risk of microorganism contamination. According to the government, these conditions significantly impacted the products’ reliability, quality, and safety. The federal and state governments also alleged that, in certain instances, Abbott failed to disclose test results indicating the presence of microorganism contamination when responding to requests from the U.S. Food and Drug Administration during inspections at the Sturgis, Michigan facility in 2019 and 2022. The national settlement resolves allegations that Abbott caused false claims to be submitted between January 1, 2018, and December 31, 2022, arising from these failures. In other words, when Abbott submitted claims to government programs for these products, the claims were considered false because the products had not been manufactured in compliance with safety standards designed to protect infants from contamination. For families, this is deeply concerning because infant formula is often the only source of nutrition for babies who are not breastfed. Even the risk of contamination is unacceptable when it comes to the most vulnerable consumers. The government’s case was built on the idea that Abbott knew the conditions were substandard and continued to sell the products anyway, allowing false claims to be paid by programs funded by taxpayers.
The settlement has special significance for Mississippi and other states because of how much infant formula is purchased through government assistance programs. The U.S. Department of Agriculture funds and regulates the Special Supplemental Nutrition Program for Women, Infants, and Children, known as WIC. WIC provides nutritional support, including infant formula, to eligible participants. More than half of all infant formula purchased in the United States is paid for with USDA funds through WIC. Many state Medicaid programs also cover and pay for certain powder infant formula. This means that when Abbott sold formula manufactured in facilities that allegedly failed to meet safety standards, the financial harm fell not only on families but on public programs that provide essential nutrition to low-income women, infants, and children. Taxpayers were effectively paying for products that were supposed to be safe, regulated, and manufactured under strict conditions, but were instead produced in environments that put them at risk of contamination. The recovery of $384 million helps compensate these programs for the funds that were spent on products that should never have been sold. It also sends a clear message to other companies that cutting corners on safety and billing government programs for substandard goods is not acceptable. The case underscores the importance of programs like WIC and Medicaid, which exist to protect people who need help the most, and the need to protect those programs from fraud and abuse.
Fitch’s quote captures the human stakes behind the legal details. “Parents should be able to trust that the infant formula they feed their babies is safe, but Abbott betrayed that trust,” she said. “My office is dedicated to protecting the integrity of the Medicaid program and ensuring that Mississippians receive the necessities that their families rely on. This settlement holds Abbott accountable for knowingly manufacturing formula in substandard conditions and defrauding taxpayers.” For parents, the idea that the formula they buy with their own money or with benefits might have been produced in unsanitary conditions is deeply unsettling. Trust is the foundation of the relationship between parents and the companies that make food for their children. When a company as established as Abbott is accused of knowingly putting that trust at risk, it damages not just the brand but the peace of mind of every parent who has ever prepared a bottle. The settlement is a formal acknowledgment that the government takes these matters seriously. It reassures the public that federal and state authorities are paying attention to the products that are paid for with public funds. By requiring Abbott to pay hundreds of millions of dollars, the settlement imposes a meaningful consequence for the alleged conduct and reinforces the importance of the False Claims Act, which is a powerful tool for protecting public health and taxpayer interests. The law allows the government to recover significant damages when companies submit false claims, which is why large settlements like this one are possible.
The total recovery of approximately $384 million is divided between the federal government and the states based on the harm done to each jurisdiction. The federal portion, about $348.7 million, resolves claims under the False Claims Act, which is the primary civil enforcement tool used by the government to combat fraud against federal programs. The state portion, about $35.5 million, resolves claims related to Medicaid, the joint federal-state program that provides health coverage to low-income individuals. Mississippi’s share of $771,432.52 represents restitution and other recoveries tied to the state’s Medicaid expenditures. The settlement is national in scope, meaning it covers allegations across all the jurisdictions that joined the agreement. It is the result of a coordinated investigation and negotiation involving state attorneys general, the U.S. Department of Justice, and other federal agencies. No single state could have uncovered the full extent of the alleged misconduct on its own. By pooling resources and information, the states and the federal government were able to build a strong case and secure a substantial recovery. This type of cooperation is essential in complex fraud cases that cross state lines and involve large corporate defendants. It also highlights the need for continued investment in enforcement programs, such as the Medicaid Fraud Control Unit, which are on the front lines of investigating these cases and protecting the integrity of government health programs.
The Mississippi Attorney General’s Office Medicaid Fraud Control Unit plays a key role in cases like this, and its ability to do so is supported by a mix of federal and state funding. The MFCU receives 75 percent of its funding from the U.S. Department of Health and Human Services under a grant totaling $3,858,572 for federal fiscal year 2026. The remaining 25 percent, totaling $1,286,190, is funded by the State of Mississippi. This funding supports investigators, auditors, attorneys, and support staff who investigate Medicaid fraud, including fraud involving manufacturers whose products are paid for by Medicaid. The Abbott settlement demonstrates why that investment matters. Without the MFCU and its federal partners, the alleged fraud might have continued, and taxpayers would have continued to pay for formula produced under substandard conditions. For Mississippi, the settlement is not just a legal victory—it is a commitment to public health and fiscal responsibility. It tells families that their government is working to ensure that the products they depend on are safe and that public programs are protected from abuse. As Fitch noted, the integrity of the Medicaid program is essential to ensuring that Mississippians receive the necessities their families rely on. This settlement is a step toward restoring that trust, and it sends a strong message that those who defraud taxpayers will be held accountable. In the end, the money recovered—$384 million nationwide and $771,432.52 in Mississippi—represents more than compensation. It is a safeguard, a deterrent, and a promise that the health of babies will not be compromised for profit.